Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Claudia Hilt"'
Publikováno v:
Clinical Case Reports, Vol 8, Iss 5, Pp 833-836 (2020)
Abstract Acute psychosis and cognitive impairment is a significant problem in RRMS. As it concerns in relatively young age group, our case report underscores the importance of early recognition which could impose diagnostic challenge in multiple scle
Externí odkaz:
https://doaj.org/article/d83b6f0f29ac4315b7e3267ae5b5873a
Autor:
Viktoria Papp, Mathias Due Buron, Volkert Siersma, Peter Vestergaard Rasmussen, Zsolt Illes, Matthias Kant, Claudia Hilt, Zsolt Mezei, Homayoun Roshanisefat, Tobias Sejbæk, Arkadiusz Weglewski, Janneke van Wingerden, Svend Sparre Geertsen, Stephan Bramow, Finn Sellebjerg, Melinda Magyari
Publikováno v:
PLoS ONE, Vol 16, Iss 5, p e0250820 (2021)
ObjectiveTeriflunomide is a once-daily, oral disease-modifying therapy (DMT) for relapsing forms of multiple sclerosis (MS). We studied clinical outcomes in a real-world setting involving a population-based large cohort of unselected patients enrolle
Externí odkaz:
https://doaj.org/article/4c38c13ec9ce425b87933408ba9724f9
Autor:
Zsolt Illes, Stephan Bramow, Volkert Siersma, Tobias Sejbaek, Homayoun Roshanisefat, Mathias Buron, Arkadiusz Weglewski, Viktoria Papp, Melinda Magyari, Zsolt Mezei, Svend Sparre Geertsen, Finn Sellebjerg, Janneke van Wingerden, Peter Vestergaard Rasmussen, Matthias Kant, Claudia Hilt
Publikováno v:
Papp, V, Buron, M D, Siersma, V, Rasmussen, P V, Illes, Z, Kant, M, Hilt, C, Mezei, Z, Roshanisefat, H, Sejbæk, T, Weglewski, A, Van Wingerden, J, Geertsen, S S, Bramow, S, Sellebjerg, F & Magyari, M 2021, ' Real-world outcomes for a complete nationwide cohort of more than 3200 teriflunomide-treated multiple sclerosis patients in the Danish Multiple Sclerosis Registry ', PLOS ONE, vol. 16, no. 5, e0250820 . https://doi.org/10.1371/journal.pone.0250820
PLoS ONE, Vol 16, Iss 5, p e0250820 (2021)
Papp, V, Buron, M D, Siersma, V, Rasmussen, P V, Illes, Z, Kant, M, Hilt, C, Mezei, Z, Roshanisefat, H, Sejbaek, T, Weglewski, A, van Wingerden, J, Geertsen, S S, Bramow, S, Sellebjerg, F & Magyari, M 2021, ' Real-world outcomes for a complete nationwide cohort of more than 3200 teriflunomide-treated multiple sclerosis patients in The Danish Multiple Sclerosis Registry ', PLoS ONE, vol. 16, no. 5, 0250820 . https://doi.org/10.1371/journal.pone.0250820
PLoS ONE
Papp, V, Buron, M D, Siersma, V, Rasmussen, P V, Illes, Z, Kant, M, Hilt, C, Mezei, Z, Roshanisefat, H, Sejbæk, T, Weglewski, A, van Wingerden, J, Geertsen, S S, Bramow, S, Sellebjerg, F & Magyari, M 2021, ' Real-world outcomes for a complete nationwide cohort of more than 3200 teriflunomide-treated multiple sclerosis patients in The Danish Multiple Sclerosis Registry ', PLOS ONE, vol. 16, no. 5, e0250820 . https://doi.org/10.1371/journal.pone.0250820
PLoS ONE, Vol 16, Iss 5, p e0250820 (2021)
Papp, V, Buron, M D, Siersma, V, Rasmussen, P V, Illes, Z, Kant, M, Hilt, C, Mezei, Z, Roshanisefat, H, Sejbaek, T, Weglewski, A, van Wingerden, J, Geertsen, S S, Bramow, S, Sellebjerg, F & Magyari, M 2021, ' Real-world outcomes for a complete nationwide cohort of more than 3200 teriflunomide-treated multiple sclerosis patients in The Danish Multiple Sclerosis Registry ', PLoS ONE, vol. 16, no. 5, 0250820 . https://doi.org/10.1371/journal.pone.0250820
PLoS ONE
Papp, V, Buron, M D, Siersma, V, Rasmussen, P V, Illes, Z, Kant, M, Hilt, C, Mezei, Z, Roshanisefat, H, Sejbæk, T, Weglewski, A, van Wingerden, J, Geertsen, S S, Bramow, S, Sellebjerg, F & Magyari, M 2021, ' Real-world outcomes for a complete nationwide cohort of more than 3200 teriflunomide-treated multiple sclerosis patients in The Danish Multiple Sclerosis Registry ', PLOS ONE, vol. 16, no. 5, e0250820 . https://doi.org/10.1371/journal.pone.0250820
Objective Teriflunomide is a once-daily, oral disease-modifying therapy (DMT) for relapsing forms of multiple sclerosis (MS). We studied clinical outcomes in a real-world setting involving a population-based large cohort of unselected patients enroll
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a475a534c4fb6343b177993f437df9c
https://vbn.aau.dk/da/publications/14313629-8b97-4183-84c4-d23d820c03f8
https://vbn.aau.dk/da/publications/14313629-8b97-4183-84c4-d23d820c03f8
Autor:
Papp, Viktoria1 (AUTHOR) papp.vittoria@gmail.com, Buron, Mathias Due2,3 (AUTHOR), Siersma, Volkert4 (AUTHOR), Rasmussen, Peter Vestergaard5 (AUTHOR), Illes, Zsolt1 (AUTHOR), Kant, Matthias6 (AUTHOR), Hilt, Claudia7 (AUTHOR), Mezei, Zsolt7 (AUTHOR), Roshanisefat, Homayoun8 (AUTHOR), Sejbæk, Tobias9 (AUTHOR), Weglewski, Arkadiusz10 (AUTHOR), van Wingerden, Janneke11 (AUTHOR), Geertsen, Svend Sparre12 (AUTHOR), Bramow, Stephan3 (AUTHOR), Sellebjerg, Finn3 (AUTHOR), Magyari, Melinda2,3 (AUTHOR)
Publikováno v:
PLoS ONE. 5/18/2021, Vol. 16 Issue 5, p1-16. 16p.
Autor:
Nandy, Anirban1 (AUTHOR) a.nandy@rn.dk, Nielsen, Michael1 (AUTHOR), Hilt, Claudia1 (AUTHOR), Mogensen, Poul Henning1 (AUTHOR), Yavarian, Yousef2 (AUTHOR)
Publikováno v:
Clinical Case Reports. May2020, Vol. 8 Issue 5, p833-836. 4p.
Autor:
Larsen, Janni Lisander, Schäfer, Jakob, Nielsen, Helle Hvilsted, Rasmussen, Peter Vestergaard
Publikováno v:
BMJ Open; Aug2020, Vol. 10 Issue 8, p1-9, 9p
Autor:
n-ails e. V.
Frauen in der Architektur sicht- und hörbar zu machen, ihnen eine Bühne zu geben, ihre Leistungen zu zeigen – das war das Anliegen des Women in Architecture Berlin Festivals 2021. Institutionen, Verbände und Initiativen im Bereich der Baukultur